Data on insulin pump use are missing, as the identification of pump users based on the type of insulin purchased is confounded by BI purchased for backup and a small proportion of patients with T2D using only fast‐acting insulin (0.1% in our study). This evidence concerns the gene INS and type 2 diabetes mellitus.